CuB treatment inhibited the expression of Wnt3/Wnt3a, inactivating GSK-3 phosphorylation, and restricted β-catenin nuclear localization to influnce interaction with TCF-1 in NSCLC cells. Here, WNT3A is linked to non-small cell lung carcinoma.